Abstract
Nine patients with polycystic ovary syndrome (PCOS) and exaggerated serum level of 17-hydroxyprogesterone (17-OHP) response to gonadotropin (GnRH) agonist stimulation, and seven patients with PCOS, but normal 17-OHP response have been analysed for possible linkage of PCOS with genetic defects on the 17α-hydroxylase/17,20-lyase gene (CYP17). A portion of the regulatory and the entire coding domain for this enzyme have been analysed by PCR-SSCP analysis. Samples have been also screened for the previously reported −34 bp polymorphism, which creates a new SP1-type promoter site, but was excluded as the primary genetic defect. We have varied gel concentrations, reduced running temperatures, added glycerol to Polyacrylamide gels and performed electrophoresis on longer gels in order to improve the resolving power of SSCP. Screening of the CYP17 gene revealed no mutations associated with the disease in the examined group of patients. Also, the −34 bp polymorphism proved to be equally distributed among patient and control samples, which in our case were non-related. The results indicate that, when germline mutations in question, CYP17 may be excluded as a candidate gene for these subtypes of PCOS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chung B., Picado-Leonard J., Haniu M., Bienkowski M., Hall P.F., Shively J.E., Miller W.L. Cytochrome P450c17(steroid 17α-hydroxylase/17, 20 lyase): Cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. USA 84: 407, 1987.
Rosenfield R.L., Randall B.B., Cara J.F., Lucky A.W. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil. Steril. 53: 785, 1990.
Adams J., Franks S., Poison D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2: 1375, 1985.
Miller S.A., Dyches D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16: 1215, 1988.
Picado-Leonard J., Miller W.L. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20-lyase): Similarity with the gene for P450c21. DNA 6: 439, 1987.
Rumsby G., Skinner C., Lee H.A., Honour J.W. Combined 17α-hydroxylase/17,20-lyase deficiency caused by heterozygous stop codons in the cytochrome P450 17α-hydroxylase gene. Clin. Endocrinol. (Oxf.) 39: 483, 1993.
Yanase T., Waterman M.R., Zachmann M., Winter J.S.D., Simpson E.R., Kagimoto M. Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg496→Cys, Gln461→Stop) actually cause combined 17α-hydroxylase/17,20-lyase deficiency. Biochim. Biophys. Acta, 1139: 275, 1992.
Imai T., Globerman H., Gertner J.M., Kagawa N., Waterman M.R. Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. J. Biol. Chem. 268(26): 1968.
Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., Franks S., Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet. 3: 1873, 1994.
Ahlgren R., Yanase T., Simpson E.R., Winter J.S.D., Waterman M.R. Compound heterozygous mutations (Arg239→Stop, Pro342→Thr) in the CYP17 (P450c17α) gene lead to ambiguous external genitalia in a male patient with partial combined 17α-hydroxylase/17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 74: 667, 1992.
Bogovich K., Richards J.S. Androgen biosynthesis in developing ovarian follicles: evidence that luteinizing hormone regulates thecal 17α-hydroxylase and C-17,20-lyase activities. Endocrinology 111: 1201, 1982.
Eckstein B., Greenbaum O., Cohen S. Kinetic studies on ovarian C-17,20-lyase activity: effect of lutenizing hormone surge. Endocr. Rev. 117: 2376, 1985.
Azziz R., Zacur A. 21-hydroxylase deficiency in female hyperandrogenism: screening and diagnosis. J. Clin. Endocrinol. Metab. 69: 577, 1989.
Pang S., Lerner A.J., Stoner E., Levine L.S., Oberfield S.E., Engel I., New M.I. Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency. A cause of hirsutism in pubertal and postpubertal women. J. Clin. Endocrinol. Metab. 60: 428, 1985.
Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N. Engl. J. Med. 330: 460, 1994.
Stewart P.M., Shackelton C.H.L., Beastall G.H., Edwards C.R.W. 5α-reductase activity in polycystic ovary syndrome. Lancet 335: 431, 1990.
Mauvais-Jarvis P. Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women. J. Clin. Endocrinol. Metab. 15: 307, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liović, M., Preželj, J., Kocijančič, A. et al. CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation. J Endocrinol Invest 20, 189–193 (1997). https://doi.org/10.1007/BF03346901
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346901